Hydrochlorothiazide and the Risk of Malignant Melanoma-Reply

JAMA Intern Med. 2018 Oct 1;178(10):1425-1426. doi: 10.1001/jamainternmed.2018.4315.

Authors

Anton Pottegård¹, David Gaist^{2

3}

Affiliations

¹ Clinical Pharmacology and Pharmacy, Department of Public Health, University of Southern Denmark, Odense, Denmark.
² Department of Neurology, Odense University Hospital, Odense, Denmark.
³ Department of Clinical Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.

PMID: 30285138
DOI: 10.1001/jamainternmed.2018.4315

No abstract available

Publication types

Comment

MeSH terms

Humans
Hydrochlorothiazide
Melanoma*
Skin Neoplasms*

Substances

Hydrochlorothiazide